FY2024 · period end Dec '24 · from the 10-K filed Mar 31, 2025
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Revenue | $77.41B | $70.57B | $96.52B | $105.63B | $58.54B |
| Gross Profit | $6.00B | $3.02B | $11.36B | $32.06B | $11.21B |
| Operating Income | negative: -$1.08B | negative: -$2.79B | $4.27B | $26.04B | negative: -$0.07B |
| Net Income | — | — | — | — | — |
| EPS (Diluted) | — | — | — | $17.57 | negative: -$8.41 |
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Total Assets | $101.58B | $91.74B | $88.05B | $92.56B | $86.08B |
| Total Liabilities | — | — | $3.01B | $4.19B | — |
| Stockholders' Equity | negative: -$4.28B | $3.28B | $6.11B | $6.21B | negative: -$3.87B |
| Cash & Equivalents | $14.99B | $14.19B | $12.47B | $8.68B | $13.86B |
| Total Debt | — | — | — | — | — |
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.44B | negative: -$2.27B | $8.95B | $14.79B | $6.29B |
| Capital Expenditures | $3.76B | $4.53B | $4.85B | $3.42B | $2.76B |
| Free Cash Flow | negative: -$1.33B | negative: -$6.80B | $4.10B | $11.37B | $3.53B |
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Gross Margin | 7.7% | 4.3% | 11.8% | 30.3% | 19.2% |
| Operating Margin | negative: -0.0% | negative: -0.0% | 0.0% | 0.2% | negative: -0.0% |
| Net Margin | 0.1% | 0.0% | 0.1% | 0.2% | 0.2% |
| Return on Equity | — | 3.7% | 102.5% | 393.0% | — |
| Return on Assets | 9.1% | 0.2% | 7.0% | 27.3% | 15.5% |
| Debt / Equity | — | 12.88× | 5.85× | 5.62× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001292814-26-002427 | Dec 31, 2025 | Apr 20, 2026 | Apr 20, 2026 20:34 UTC | EDGAR |
| 20-F | 0001292814-25-001192 | Dec 31, 2024 | Mar 31, 2025 | Mar 29, 2025 01:59 UTC | EDGAR |
| 20-F | 0001292814-24-001348 | Dec 31, 2023 | Apr 12, 2024 | Apr 12, 2024 10:06 UTC | EDGAR |
| 20-F | 0001292814-23-001738 | Dec 31, 2022 | Apr 25, 2023 | Apr 25, 2023 00:34 UTC | EDGAR |
| 20-F | 0001292814-22-001862 | Dec 31, 2021 | Apr 28, 2022 | Apr 28, 2022 02:01 UTC | EDGAR |
| 20-F | 0001292814-21-002286 | Dec 31, 2020 | May 14, 2021 | May 14, 2021 01:17 UTC | EDGAR |
| 20-F | 0001292814-20-002229 | Dec 31, 2019 | Jun 15, 2020 | Jun 13, 2020 01:31 UTC | EDGAR |
| 20-F | 0001292814-19-003452 | Dec 31, 2018 | Oct 17, 2019 | Oct 17, 2019 21:27 UTC | EDGAR |
Direct links to SEC EDGAR. BAK has additional filings available on the SEC site.
6 numbers BRASKEM SA later changed — same XBRL tag, both filings linked.
GrossProfit·FY 2018
Minor restatementwas11.6BBRL
Revised down in a 20-F.
PretaxIncome·FY 2022
Minor restatementwas47.3MBRL
Revised down in a 20-F.
ShortTermDebt·As of Dec 31, 2022
Major restatementwas1.3BBRL
Revised up in a 20-F.
LongTermDebt·As of Dec 31, 2022
Notable restatementwas31.3BBRL
Revised up in a 20-F.
ComprehensiveIncome·FY 2019
Minor restatementwas-1.6BBRL
Revised down in a 20-F.
GeneralAndAdmin·FY 2016
Major restatementwas191.6MBRL
Revised up in a 20-F.
BAK is not the only one.
See every restatement we've found across the market — or get an alert the next time BAK revises a number.
Restatements are detected by comparing every vintage of a fact across all of BRASKEM SA's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows BAK's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling BRASKEM SA — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on BAK yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BAK and publish the result to your public profile.
Ask about BRASKEM SA
Continue in Workspace — cited answers on BAK, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs